TABLE 1.

Characteristics of the Study Sample and Bivariate Associations with QOL (N=830)

Variable	N	%	QOL a Mean or Correl.	SD	P-value b
Demographics
Gender
Male	418	50.3	85.5	16.9	.917
Female	412	49.7	85.6	16.6
Race
Caucasian	718	86.5	86.3	16.3	.002
Non-Caucasian c	112	13.5	80.5	18.7
Ethnicity
Hispanic	13	1.6	85.5	16.8	.986
Non-Hispanic	817	98.4	85.5	16.8
Income level			r = .225		<.001
< $30,000	205	27.3	79.0	19.5	ref<.001
$30,000 – $59,999	229	30.5	86.1	16.5	<.001
$60,000 – $89,999	136	18.1	86.9	14.7	<.001
≥ $90,000	181	24.1	90.0	13.7	<.001
Education			r = .115		<.001
High school or less	228	27.8	82.3	18.2	<.001
Some college or trade school	263	32.1	84.9	17.7	.014
College or post-grad	328	40.1	88.3	14.4	ref<.001
Marital status
Married	618	74.6	86.5	16.4	.005
Not married d	210	25.4	82.7	17.5
Employment status
Employed	334	40.7	87.6	15.7	.005
Not employed e	487	59.3	84.3	17.3
Age at enrollment: mean (SD)	62.8	(13.3)	r = .099		.054
25–49	149	18.0	83.4	20.0	ref.001
50–64	303	36.5	83.4	16.7	.984
65–79	294	35.4	87.9	15.4	.016
≥80	84	10.1	88.7	13.9	.020
Clinical Characteristics
NHL histology
Indolent	414	52.7	84.8	17.3	.097
Aggressive	372	47.3	86.8	16.1
NHL stage at diagnosis			r = −.077		.038
Stage I	228	31.6	87.8	15.4	ref<.202
Stage II	149	20.6	86.2	15.4	.335
Stage III	145	20.1	84.9	18.5	.101
Stage IV	200	27.7	84.7	17.3	.049
Sum of treatment types: mean (SD)	2.1	(1.1)	r = −.153		<.001
Current treatment status
Not in treatment	711	86.6	86.7	16.3	<.001
Receiving treatment	110	13.4	78.6	18.3
NHL disease status
In remission or cured	648	78.0	87.8	15.0	<.001
Not in remission	102	12.3	75.2	20.0
Number of NHL recurrences
0	534	65.9	86.9	16.3	.003
≥1	276	34.1	83.2	17.4
Frequency of NHL-related exams			r = −.234		<.001
Age at diagnosis: mean (SD)	52.4	(14.1)	r = .038		.279
Range:	19–87
Years since diagnosis: mean (SD)	10.4	(7.3)	r = .108		.002
2–4 yrs	202	24.4	84.5	17.1	ref.010
5–9 yrs	307	37.0	84.6	17.4	.909
10–14 yrs	143	17.1	85.0	15.9	.772
15–19 yrs	85	10.3	85.8	17.1	.533
≥20 yrs	93	11.2	91.4	13.9	<.001
Health Status
Secondary cancer
Yes	113	13.7	83.8	15.8	.205
No	711	86.3	85.9	16.8
Co-morbidities: mean (SD)	2.9	(2.2)	r = −.387		<.001
Years since last physical exam			r = −.119		.001
Psychosocial
Social support: mean (SD)	83.3	(16.3)	r = .490		<.001
Range:	20–100
Appraisal of life threat and treatment intensity: mean (SD)	19.4	(5.9)	r = −.285		<.001
Range:	6–30
Employment and insurance issues related to cancer: mean (SD)	1.1	(2.1)			<.001
Range:	0–17
Psychological Effects
PTSD symptom clusters: mean (SD)	0.6	(0.9)	r = −.621		<.001
Range:	0–3
Post-traumatic growth: mean (SD)	60.4	(24.6)	r = .133		<.001
Range:	0–105
FACT-G Outcomes: mean (SD)
Physical	22.8	(5.6)
Emotional	19.6	(4.1)
Functional	20.8	(6.1)
Social/Family	22.3	(5.0)

Note: Not all variables represent n=830 cases due to missing data; range, 722–830.

^aQuality of life as measured by the Functional Assessment of Cancer Therapy – General Version

^bP-values shown as superscripts are for the overall F-test for the categorical variable with k-1 degrees of freedom where k is the number of categories.

^cAfrican-American, American Indian/Alaskan, Asian, and multiple races.

^dWidowed, separated, divorced, and single.

^eUnemployed and retired.